Stay updated on Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.

Latest updates to the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page
- Check5 days agoChange DetectedKey descriptors like the drug and diseases, plus associated indexing terms, were removed from the study record, and related metadata was reduced, which changes how the study is described and located within the platform.SummaryDifference17%

- Check12 days agoChange DetectedRevision: v3.7.0 was added to the page footer, replacing Revision: v3.6.6. This indicates a version/template update for the study page.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.6.6 is now displayed on the page, replacing the previous v3.6.5. This reflects a routine update to the site's documentation or underlying components rather than a change to study content.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page's Revision tag was updated from v3.6.4 to v3.6.5, indicating a minor update to the ClinicalTrials.gov record without altering the study details.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 on the page, signaling a new version of the record. This appears to be an internal update rather than a modification to the study details.SummaryDifference0.1%

- Check90 days agoChange DetectedA new revision tag v3.6.3 was added and the old v3.6.0 tag was removed, signaling an updated page revision.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.